Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05819619 · ClinicalTrials.gov registry record · Early Phase 1
Prophylactic Analgesic and Antiemetic Regimen for Medical Abortion < 70 Days
A Early Phase 1 study, sponsored by Hackensack Meridian Health.
- Terminated
- Registry status
- Early Phase 1
- Development phase
- 8
- Enrollment target
NCT05819619: Clinical Trial Early Phase 1 study, sponsored by Hackensack Meridian Health.
NCT05819619 is a Early Phase 1 study that was terminated before completion, run by Hackensack Meridian Health. The registered enrollment target is 8 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05819619, a Early Phase 1 study, was terminated before completion, sponsored by Hackensack Meridian Health.
- TERMINATED
- Registry status
- Early Phase 1
- Development phase
- 8 participants
- Enrollment target
Study Summary
Randomized trial which will aim to evaluate whether prophylactic use of ondansetron and ibuprofen will decrease side effects associated with medical abortion and increase patient satisfaction.
Primary Outcome
Determine if prophylactic use of ondansetron and ibuprofen during medical abortion treatment can increase patient satisfaction thereby creating a more favorable outcome. Patient satisfaction will be assessed using a home developed survey. Satisfaction is measured on 5-Likert scale ranging from Very satisfied to Very dissatisfied.
Interventions
- DRUG Prophylactic use of ibuprofen and ondansetron post misoprostol administration
- DRUG Use of ibuprofen and ondansetron at symptom onset post misoprostol administration
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2023-07-20 |
| Est. Completion | 2024-04-11 |
| Phase | Early Phase 1 |
Why NCT05819619 stopped before completion
NCT05819619 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (85% lower).
The record links to 0 conditions, and to 2 interventions - of which Prophylactic use of ibuprofen and ondansetron post misoprostol administration is the first listed.
NCT05819619 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05819619 about?
NCT05819619 is a clinical study titled "Prophylactic Analgesic and Antiemetic Regimen for Medical Abortion < 70 Days". Randomized trial which will aim to evaluate whether prophylactic use of ondansetron and ibuprofen will decrease side effects associated with medical abortion and increase patient satisfaction.
What is the current status of trial NCT05819619?
This trial is currently terminated. It is a Early Phase 1 study. The enrollment target is 8 participants. The study started on 2023-07-20. Estimated completion is 2024-04-11.
What interventions are being tested in trial NCT05819619?
The interventions under investigation include: Prophylactic use of ibuprofen and ondansetron post misoprostol administration (DRUG), Use of ibuprofen and ondansetron at symptom onset post misoprostol administration (DRUG).
Who is sponsoring clinical trial NCT05819619?
This trial is sponsored by Hackensack Meridian Health, which has 90 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05819619's enrollment target sits among peer trials
8 1782nd of 2000 higher than 176 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI